Digital therapeutics pioneer Kaia Health, creator of one of the world’s leading back pain apps, has raised $10m in a Series A round led by Balderton Capital.
The investment will be used to support Kaia’s US rollout, including a new office in New York City and fund further clinical studies.
Since launching in 2016, Kaia Health, has created scientifically-validated digital treatments for a range of disorders including back pain and COPD.
Its Kaia back pain app has been adopted by over 250,000 individuals as well as organisations across Europe and the US. This includes some of Europe’s biggest health insurance companies, such as BARMER.
Konstantin Mehl, co-founder and CEO of Kaia Health, says: “Over the last twelve months, we’ve demonstrated a universal, unmet need for affordable and accessible digital therapy products, such as our world’s first computer vision-powered back pain app. These improve treatment paths for patients and reduce costs for payers in healthcare around the globe. Balderton’s investment will support the next stage of our journey, as we expand across the US, undertake further clinical studies and cement our position as a global leader in the digital healthcare market.”
(picture shows the Kaia Health team)
